Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
1 study found for:    23901077 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed
Has Results 		Immunogenicity and Reactogenicity of Alternative Schedules of Gardasil
Condition: Dose Schedule Study
Intervention: Biological: Biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine
To Top

† Indicates status has not been verified in more than two years